Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.5K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.5K
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

24
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
24
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

20
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
20
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

266
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
266
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

17
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
17
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

509
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
509

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mental health outcomes of living related donors for recipients with alcohol-associated hepatitis.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Implications of Liver Failure Cutoffs for Mortality Prediction in Hospitalized Cirrhosis Patients: A Multicentric Study.

Gastro hep advances·2026
Same author

Overlap Syndromes and Associated Immunoglobulin-G4-Related Liver Diseases.

Journal of clinical and experimental hepatology·2026
Same author

Shifting epidemiology and disease severity: Rethinking India's hepatitis A strategy in the context of acute liver failure.

Journal of family medicine and primary care·2026
Same author

Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective.

Gut·2026
Same author

Validation of a Low-Cost Handheld Dynamometer Against a Standard Device for Handgrip Strength Assessment in Stable Outpatients with Cirrhosis.

Journal of frailty, sarcopenia and falls·2026

Related Experiment Video

Updated: Apr 21, 2026

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
08:15

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

1.7K

Recompensation in Patients With Alcohol-Related Liver Disease-A Multicenter Study.

Anand V Kulkarni1, Madhumita Premkumar2, Karan Kumar3

  • 1Department of Hepatology, AIG Hospitals, Hyderabad, India.

Gastro Hep Advances
|April 20, 2026
PubMed
Summary
This summary is machine-generated.

Twenty percent of patients with alcohol-related liver disease achieved recompensation, improving transplant-free survival. Key predictors included duration of abstinence and Child score, highlighting the importance of sustained sobriety for liver recovery.

Keywords:
Alcoholic HepatitisAscitesBavenoPortal Hypertension

More Related Videos

The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

10.0K
The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
05:40

The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans

Published on: April 28, 2022

3.9K

Related Experiment Videos

Last Updated: Apr 21, 2026

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
08:15

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

1.7K
The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

10.0K
The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
05:40

The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans

Published on: April 28, 2022

3.9K

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Cirrhosis recompensation is possible with etiological factor removal.
  • Limited data exists on recompensation rates in viral cirrhosis.
  • This study focuses on alcohol-related liver disease (ALD).

Purpose of the Study:

  • To assess recompensation rates in alcohol-related liver disease (ALD).
  • To identify predictors of recompensation in ALD patients.
  • To evaluate the impact of recompensation on survival outcomes.

Main Methods:

  • Retrospective multicenter cohort study.
  • Inclusion of patients with a spectrum of ALD.
  • Data collection on clinical and biochemical parameters, followed by endpoint evaluation.

Main Results:

  • 20% of 344 ALD patients achieved recompensation (Baveno VII criteria).
  • Higher recompensation rate in decompensated cirrhosis without alcohol-associated hepatitis (DC-AAH) vs. with (DC+AAH).
  • Recompensation was linked to improved transplant-free survival.

Conclusions:

  • Recompensation is achievable in 20% of ALD patients.
  • Abstinence duration and Child score predict recompensation.
  • Recompensation significantly improves survival in ALD.